Search

everythinglearnresearchcommunity

for

Search:↓

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The serum improves facial skin quality safely and effectively.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

RXRα is crucial for proper immune response and links diet to immune function.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

JAK inhibitors offer new hope for treating severe alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

STITCH improves suture accuracy and efficiency, especially with human help.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

JAK inhibitors may help improve symptoms in adults with APECED.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.